Overview

Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer

Status:
Unknown status
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This research study hopes to examine the effects of Coenzyme Q10 on doxorubicin (Adriamycin) metabolism during breast cancer treatment.
Phase:
Phase 1
Details
Lead Sponsor:
Heather Greenlee
Collaborator:
National Institutes of Health (NIH)
Treatments:
Coenzyme Q10
Doxorubicin
Liposomal doxorubicin
Ubiquinone